JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
Wayfair
W
$13.9B
| $2.23M | ﹤0.01% |
20,100
-684,700
| -97% | -$96.4M |
|
3502
CALL
Paylocity
PCTY
$7.87B
| $2.22M | ﹤0.01% |
+10,800
| New | +$2.19M |
|
3503
Children's Place
PLCE
$54.3M
| $2.22M | ﹤0.01% |
44,948
+11,734
| +35% | +$746K |
|
|
ADVM
3504
DELISTED
Adverum Biotechnologies
ADVM
| $2.21M | ﹤0.01% |
168,727
-37,369
| -18% | -$547K |
|
|
LOVE
3505
LoveSac
LOVE
$253M
| $2.21M | ﹤0.01% |
40,858
+22,872
| +127% | +$1.1M |
|
3506
CALL
Marqeta
MQ
$1.7B
| $2.21M | ﹤0.01% |
+50,000
| New | +$2.32M |
|
3507
PUT
SSR Mining
SSRM
$6.56B
| $2.21M | ﹤0.01% |
+101,500
| New | +$1.91M |
|
3508
Ascendis Pharma A/S
ASND
$16.3B
| $2.21M | ﹤0.01% |
18,809
+1,530
| +9% | +$177K |
|
3509
CALL
Sabre
SABR
$900M
| $2.21M | ﹤0.01% |
192,900
+169,700
| +731% | +$1.66M |
|
|
FBMS
3510
DELISTED
The First Bancshares, Inc.
FBMS
| $2.2M | ﹤0.01% |
65,412
-19,094
| -23% | -$693K |
|
3511
iShares MSCI Intl Value Factor ETF
IVLU
$4.55B
| $2.2M | ﹤0.01% |
86,511
+85,616
| +9,566% | +$2.22M |
|
|
APLS
3512
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $2.2M | ﹤0.01% |
+43,300
| New | +$1.91M |
|
|
FRON
3513
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
| $2.2M | ﹤0.01% |
+224,723
| New | +$2.19M |
|
3514
American Vanguard Corp
AVD
$62.5M
| $2.2M | ﹤0.01% |
108,105
+4,563
| +4% | +$74.6K |
|
|
BURU
3515
DELISTED
NUBURU INC
BURU
| $2.2M | ﹤0.01% |
+1,112
| New | +$2.19M |
|
3516
Quanterix
QTRX
$122M
| $2.2M | ﹤0.01% |
75,228
+906
| +1% | +$27.7K |
|
3517
The Bancorp
TBBK
$2.84B
| $2.19M | ﹤0.01% |
77,368
+42,423
| +121% | +$1.22M |
|
|
BBBY
3518
Bed Bath & Beyond
BBBY
$415M
| $2.19M | ﹤0.01% |
54,682
+5,161
| +10% | +$229K |
|
|
LOCC
3519
DELISTED
Live Oak Crestview Climate Acquisition Corp.
LOCC
| $2.19M | ﹤0.01% |
225,228
+96,985
| +76% | +$938K |
|
3520
Televisa
TV
$1.53B
| $2.18M | ﹤0.01% |
186,523
-7,759
| -4% | -$80.4K |
|
|
KDNY
3521
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.18M | ﹤0.01% |
133,150
+2,985
| +2% | +$40.6K |
|
3522
Mustang Bio
MBIO
$4.5M
| $2.17M | ﹤0.01% |
2,873
-190
| -6% | -$156K |
|
3523
CALL
Altria Group
MO
$110B
| $2.17M | ﹤0.01% |
41,600
+18,900
| +83% | +$963K |
|
|
STKL
3524
DELISTED
SunOpta
STKL
| $2.17M | ﹤0.01% |
432,794
+93,798
| +28% | +$495K |
|
|
ZIMV
3525
DELISTED
ZimVie
ZIMV
| $2.17M | ﹤0.01% |
+95,030
| New | +$2.24M |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.